Skip to main content
. 2022 Mar 9;45(5):1211–1218. doi: 10.2337/dc21-1138

Figure 2.

Figure 2

Life-years free of new/recurrent CVD events gained by adding semaglutide to SoC, by age-group. *Estimated glomerular filtration rate <60 mL/min/1.73 m2 (estimated using the CKD-EPI creatinine equation) and no established CVD. Error bars show interquartile range. CV, cardiovascular.